Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired Pneumonia

Detalles Bibliográficos
Autor principal: Schuetz, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068823/
https://www.ncbi.nlm.nih.gov/pubmed/31800293
http://dx.doi.org/10.1164/rccm.201910-1970LE
_version_ 1783505650691604480
author Schuetz, Philipp
author_facet Schuetz, Philipp
author_sort Schuetz, Philipp
collection PubMed
description
format Online
Article
Text
id pubmed-7068823
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Thoracic Society
record_format MEDLINE/PubMed
spelling pubmed-70688232020-03-15 Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired Pneumonia Schuetz, Philipp Am J Respir Crit Care Med Correspondence American Thoracic Society 2020-03-15 2020-03-15 /pmc/articles/PMC7068823/ /pubmed/31800293 http://dx.doi.org/10.1164/rccm.201910-1970LE Text en Copyright © 2020 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). For commercial usage and reprints, please contact Diane Gern (dgern@thoracic.org).
spellingShingle Correspondence
Schuetz, Philipp
Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired Pneumonia
title Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired Pneumonia
title_full Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired Pneumonia
title_fullStr Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired Pneumonia
title_full_unstemmed Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired Pneumonia
title_short Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired Pneumonia
title_sort procalcitonin is useful for evaluating patients with ambiguous presentation and for early discontinuation of antibiotics in community-acquired pneumonia
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068823/
https://www.ncbi.nlm.nih.gov/pubmed/31800293
http://dx.doi.org/10.1164/rccm.201910-1970LE
work_keys_str_mv AT schuetzphilipp procalcitoninisusefulforevaluatingpatientswithambiguouspresentationandforearlydiscontinuationofantibioticsincommunityacquiredpneumonia

Ejemplares similares